Mirum Pharmaceuticals, Inc. — Director's Dealing 2021

Mar 9, 2021

SEC Form 4/A — Form 4/A

Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2021-01-07

Reporting Person: Longpre Lara (Chief Development Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-07	Stock Option (right to buy)	$19.19	A	65000	Acquired	2031-01-06	Common Stock (65000)	Direct

Footnotes

F1: This Form 4 is being amended to correct the transaction date.

F2: 1/4th of the shares vest one year after January 7, 2021 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.